Synthesis and Evaluation of Potentially Transdermal Morphine Derivatives

Article

<< Previous

Next >>

Contents Vol 64(10)

doi:10.1071/CH11029

An international journal for chemical science

	Search




	Advanced Search



	Journal Home

	About the Journal

	Editorial Board

	Contacts

	For Advertisers



	Content

	Online Early

	Current Issue

	Just Accepted

	All Issues

	Virtual Issues

	Special Issues

	Research Fronts

	Sample Issue

	Covers



	For Authors

	General Information

	Notice to Authors

	Submit Article

	Open Access



	For Referees

	Referee Guidelines

	Review Article



	For Subscribers

	Subscription Prices

	Customer Service

	Print Publication Dates

e-Alerts

Subscribe to our Email Alert or

feeds for the latest journal papers.

Connect with us

Affiliated with RACI

Royal Australian
Chemical Institute

Synthesis and Evaluation of Potentially Transdermal Morphine Derivatives

Jacqui F. Young ^A , Neeranat Thienthong ^A , Milton T. W. Hearn ^A , Andrea J. Robinson ^A and W. Roy Jackson ^A ^B

^A Centre for Green Chemistry, Monash University, Clayton, Vic. 3800, Australia.
^B Corresponding author. Email: roy.jackson@monash.edu

Australian Journal of Chemistry 64(10) 1339-1345 http://dx.doi.org/10.1071/CH11029
Submitted: 17 January 2011 Accepted: 16 May 2011 Published: 23 August 2011





	PDF (243 KB) $25



	Export Citation

Print

Abstract

Three new morphine-based compounds bearing arginyl moieties, compounds 7, 9a, and 9b, have been synthesized using solid phase and solution phase techniques with the aim of obtaining new transdermal analgesics. Preliminary biological assays have shown that these compounds have a relatively high affinity for opioid receptors, achieving ≥94 % inhibition of radioligand binding at a concentration of 10 µM in non-selective opioid binding assays. Further testing on two of the analogues, 9a and 9b, demonstrated that these compounds were acting as agonists, rather than antagonists, at the opioid receptors and 9b achieved the significant result of 73 % inhibition of contractile responses in the electrically stimulated guinea pig ileum assay at a concentration of 30 µM. Unfortunately, none of the molecules showed evidence of transdermal activity.

References

[1] F. Stain, M. J. Barjavel, P. Sandouk, M. Plotkine, J. Scherrmann, H. N. Bhargava, Pharmacol. Exp. Ther. 1995, 274, 852.

[2] E. Eisenberg, E. D. McNicol, D. B. Carr, J. Am. Med. Ass. 2005, 293, 3043.
| CrossRef |

[3] A. Chang, A. Cowan, A. E. Taekemori, P. S. Portoghese, J. Med. Chem. 1996, 39, 4478.
| CrossRef |

[4] A. Herz, Opioid Peptides, Opioid Receptors and Peripheral Analgesia, in The Pharmacology of Opioid Peptides 1995, pp. 287–301 (Ed. L. F. Tseng) (Harwood Academic Publishers: Singapore).

[5] W. Janson, C. Stein, Curr. Pharm. Biotechnol. 2003, 4, 270.
| CrossRef |

[6] J. L. Junien, J. G. Wettstein, Life Sci. 1992, 51, 2009.
| CrossRef |

[7] W. Puehler, C. Zollner, A. Brack, M. A. Shaqura, H. Kraus, M. Schäfer, C. Stein, Neurosci. 2004, 129, 473.
| CrossRef |

[8] Z. Helyes, Arthritis Rheum. 2005, 52, 2955.
| CrossRef |

[9] W. R. Jackson, F. C. Copp, J. D. Cullen, F. J. Guyett, I. D. Rae, A. J. Robinson, H. Pothoulackis, A. K. Serelis, M. Wong, Clin. Exp. Pharmacol. Physiol. 1992, 19, 17.
| CrossRef |

[10] K. R. Subasinghe, W. R. Jackson, J. F. Young, M. Papanastasiou, B. Jarrott, Aust. J. Chem. 2004, 57, 427.
| CrossRef |

[11] K. M. M. Doan, S. S. Lakhman, K. M. K. Boje, Brain Res. 2000, 876, 141.
| CrossRef |

[12] S. I. Deutsch, W. H. Oldendorf, K. L. Davis, Life Sci. 1984, 34, 2279.
| CrossRef |

[13] J. B. Rothbard, S. Garlington, Q. Lin, T. Kirschberg, E. Kreider, P. L. McGrane, P. A. Wender, P. A. Khavari, Nat. Med. 2000, 6, 1253.
| CrossRef |

[14] W. C. Chan, P. D. White, FMOC Solid Phase Peptide Synthesis – A Practical Approach 2000 (Oxford University Press: New York, NY).

[15] M. D. S. Loose, G. C. Rosenfield, Pharmacology 1998, p. 408 (Lippincott Williams & Wilkins: Maryland, USA).

[16] B. A. Jordan, S. Cvejic, L. A. Devi, Neuropsychopharmacology 2000, 23, S5.
| CrossRef |

[17] C. Stein, A. Yassouridis, Pain 1997, 71, 119.
| CrossRef |

[18] J. F. Young, N. Thienthong, M. T. W. Hearn, W. R. Jackson, Synlett 2011, 6, 831.

[19] W. Zhang, M. J. Robins, Tetrahedron Lett. 1992, 33, 1177.
| CrossRef |

[20] J. Wang, P. S. Johnson, A. M. Persico, A. L. Hawkins, C. A. Griffin, G. R. Uhl, FEBS Lett. 1994, 338, 217.
| CrossRef |

[21] P. Maguire, N. Tsai, J. Kamal, C. Cometta-Morini, C. Upton, G. Loew, Eur. J. Pharmacol. 1992, 213, 219.
| CrossRef |

[22] F. Simonin, C. Gaveriaux-Ruff, K. Befort, B. Lannes, G. Micheletti, M. Mattei, G. Charron, B. Bloch, B. Kieffer, Proc. Natl. Acad. Sci. USA 1995, 92, 7006.
| CrossRef |

[23] S. R. Childers, I. Creese, A. M. Snowman, S. H. Snyder, Eur. J. Pharmacol. 1979, 55, 11.
| CrossRef |

[24] G. W. Pasternak, A. Wilson, S. H. Snyder, Mol. Pharmacol. 1974, 11, 340.

[25] H. Moritoki, M. Morita, T. Kanbe, Eur. J. Pharmacol. 1976, 35, 185.
| CrossRef |

Subscriber Login

	Username: Password:

Legal & Privacy | Contact Us | Help